ARG1 and neoplasm: To further illustrate the effect of ART on the immune landscape of in situ tumor microenvironment, we used immunohistochemistry to detect the M1 marker iNOS and M2 marker ARG1 of MDSCs (Gr-1+ cells) and macrophages (F4/80+ cells).